Saturna Capital Corp Dr Reddys Laboratories LTD Transaction History

Saturna Capital Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 10, 2018	SELL	$31.93 - $39.54 $383,160 - $474,480	-12,000 Closed	0 $0
Q4 2017 Feb 06, 2018	SELL	$34.15 - $37.62 $221,975 - $244,529	-6,500 Reduced 35.14%	12,000 $451,000
Q3 2017 Nov 14, 2017	BUY	$30.11 - $37.72 $31,615 - $39,606	1,050 Added 6.02%	18,500 $660,000
Q2 2017 Aug 14, 2017	BUY	N/A	17,450	17,450 $735,000

245

23.2M

12.7K

6.1K

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $2.56B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

Get notified when there are updates to the investment portfolio of Saturna Capital Corp, based on Form 13F filings with the SEC.

Stay updated on Saturna Capital Corp with notifications on news.